GENE ONLINE|News &
Opinion
Blog

Merck
ESMO 2024 highlights
Highlights from ESMO 2024: Key Oncology Advances from Major Pharmaceutical Companies
2024-09-19
R&D MerckKeytruda
Merck’s KEYTRUDA Fails in Early-Stage Lung and Skin Cancer Trials, Ends Two Phase 3 Studies
2024-08-30
Deals Acquisitions
Merck Strikes $1.3 Billion Deal to Acquire Curon’s B-Cell Therapy Drug
2024-08-12
Ranking & Reports MerckQ2 Report
Merck Reports Robust Q2 Growth and Expands Drug Portfolio
2024-08-06
Funding ADCSeries A Funding
$115M Series A Boosts Myricx Bio’s ADC Development with Lilly and Novo Support
2024-07-11
ASCO 2024 ASCO 2024US BIO
Merck Buys EyeBio for $3B and Shares Global Policy Perspectives During BIO in San Diego
2024-06-20
ASCO 2024 ASCO 2024ASCO Releases
Merck’s KEYNOTE-522 Success; BMS Licenses PRX019, Prothena Gets $80M
2024-06-19
Partnerships Synthetic BiologyMerckStartup
Pearl Bio Enters $1 Billion Partnership Agreement with MSD for Biologic Therapies
2024-03-13
Manufacturing Novo NordiskJohnson & JohnsonAmgenBristol Myers SquibbAstraZenecaMerck KGaAModernaDaiichi Sankyo
Pharmaceutical Giants Expand Research and Manufacturing Capabilities, Fueling 2024 Innovation and Growth
2024-03-01
Editors' Picks Healthcare Industrybiotechbiopharma
GeneOnline’s Pick – Top 10 Global Industry News Stories in 2023 (Part 2)
2024-01-15
Editors' Picks weekly highlights
GeneOnline’s Weekly News Highlights: Nov 20-Nov 24
2023-11-27
Editors' Picks weekly highlights
GeneOnline’s Weekly News Highlights: Oct 16-Oct 20
2023-10-24
Feature BIO Asia-Taiwan 2023
GeneOnline’s Weekly News Highlights: July 24-28
2023-08-01
M&A MerckAutoimmune Disease
Merck Buys Prometheus For $10.8 Billion, Lands Promising Autoimmune Asset
2023-04-17
Trials & Approvals ModernaCancer Vaccine
Moderna’s Cancer Vaccine to Enter Phase 3 Trials This Year
2023-04-17
1 2 3 … 7
LATEST
Bayer’s NUBEQA: Breakthrough in Prostate Cancer with 46% Risk Reduction and Future FDA Expansion Plans
2024-09-19
Five Biotech Stocks Soar: Eyes on Halozyme, United Therapeutics, Harmony, Ligand, and ADMA
2024-09-19
Biotech Industry Trends in 2024: A Look at the Billions in Oncology Deals
2024-09-18
Thailand’s Biotech Boom: Innovations in Precision Medicine, Cell Therapy, and Wellness Drive APAC Leadership
2024-09-18
International Green Party Showcases AI Solutions for a Healthy and Sustainable Future
2024-09-16
Bio Asia Pacific 2024 Close ASEAN Collaborations: Catalyzing Innovation and Global Partnerships
2024-09-12
Illumina’s IVD Biomarker Test Becomes the First FDA-approved Pan-cancer Companion Diagnostics Kit
2024-09-11
READ MORE
EVENT
2024-10-09
Medical Japan 2024 Tokyo
Tokyo, Japan
2024-10-10
BioJapan / Regenerative Medicine Japan / healthTECH JAPAN 2024
Tokyo, Japan
2024-10-15
BIO Investor Forum 2024
San Francisco, U.S.A.
SEE MORE
Newsletter

Subscribe to receive updates.

SIGN UP
Facebook
Youtube
Twitter
Linkedin
About
Explore
More
© 2024 GeneOnline
Privacy Policy | Terms of Service
Privacy Policy | Terms of Service
  • Subscribe to our newsletter and dive into the world of biopharma with us.
SIGN UP
x
Scroll to Top